Home
> Transparency Posts > Transparency Meeting with Investors & FDA
Transparency Meeting with Investors & FDA
August 12, 2009
Attendees
Transparency Meeting with Investors & FDA
August 11, 2009, 9:30 – 11:00am, EEOB 350
Barry Eisenstein, Cubist
Scott Minick, ARCH
Jonathan Flemming, Oxbio
John H. Griffin, Numerate, Inc.
Mike Ross, SV Life Sciences
Michael Doherty, Genentech
Vern Norviel, WSGR
Jonathan Fleming, Oxford Bioscience Partners
William Rosenzweig, Physic Ventures
Jonathan S. Leff, Warburg Pincus
Kelly Slone, NVCA
Justin Klein, NEA
